Most people can take advantage of IV therapy, but it may not be suitable for those with certain medical conditions like heart disease or kidney issues
Key Comparison: Effectiveness, Safety, and Access Both options aim to support weight loss and metabolic health
The once-weekly injectable, which gained unprecedented market traction for its weight-loss efficacy, is set to go off-patent in India later this week, opening the floodgates for cheaper generic alternatives
Each year, around 1 October, the World Anti-Doping Agency (WADA) publishes a new Prohibited List its list of what substances and methods are banned in international sport
Other oral antidiabetic medications, including SGLT2 inhibitors and DPP-4 inhibitors, are generally not recommended during breastfeeding due to limited safety data